State

Massachusetts product recalls

72,971 recalls have nationwide distribution and so reach Massachusetts. 8,211 additional recalls listed Massachusetts specifically in their distribution scope.

What the numbers show

Total: 8,211
Critical: 1,171
Severe: 2,013
Most recent: 2026-09-16

Of the 8,211 recalls naming Massachusetts we have scored against our rubric, 1,171 (14%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 2,013 (25%) are Severe.

Which agencies issued them

These figures cover only the 8,211 recalls whose distribution notice names Massachusetts specifically. The 72,971 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

5926–5950 of 81182

HighFDA (Drugs)·D-0562-2025·2025-08-13
Compounded semaglutide and cyanocobalamin vials recalled over lack of processing controls
Semaglutide + Cyanocobalamin 0.88 mg + 0.25 mg/0.5 mL injection solution compounded by Aequita Pharmacy is being recalled for lack of processing controls. 194 vials are affected.
Product
Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Category
Drug
Distribution
1 state
HighFDA (Drugs)·D-0568-2025·2025-08-13
Direct Rx duloxetine 30 mg capsules exceed the interim nitrosamine limit
Duloxetine Delayed-Release 30 mg capsules packaged by Direct Rx are being recalled because a nitrosamine drug substance related impurity was present above the proposed interim limit. 875 bottles affected.
Product
Duloxetine D/R, 30 mg, 30 Caps, RX Only, Packaged as a) 30-count bottle NDC 61919-0482-30, b) 60-count bottle, NDC 61919-0482-60, c) 90-count bottle, NDC 61919-0482-90; Packaged & Distributed by: Direct Rx, Dist. By Breckenridge Pharm., Inc., Berlin, CT 06037,
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0564-2025·2025-08-13
Compounded semaglutide 2.21 mg vials recalled over lack of processing controls
Semaglutide + Cyanocobalamin 2.21 mg + 0.25 mg/0.5 mL injection solution compounded by Aequita Pharmacy is being recalled for lack of processing controls. 176 vials are affected.
Product
Semaglutide + Cyanocobalamin injection solution, 2.21 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Category
Drug
Distribution
1 state
HighFDA (Drugs)·D-0552-2025·2025-08-13
Duloxetine 60 mg capsules exceed the safety assessment limit for nitrosamine
Duloxetine Delayed-Release Capsules USP 60 mg distributed by Breckenridge are being recalled because N-nitroso-duloxetine was present above the safety assessment limit. 1,829 bottles affected.
Product
DULOXETINE — DULOXETINE (DULOXETINE HYDROCHLORIDE)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0554-2025·2025-08-13
Compounded tirzepatide and niacinamide vials recalled over lack of processing controls
Tirzepatide + Niacinamide 2.2 mg + 1.0 mg/0.5 mL injection solution compounded by Aequita Pharmacy is being recalled for lack of processing controls. 236 vials are affected.
Product
Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Category
Drug
Distribution
1 state
HighFDA (Drugs)·D-0567-2025·2025-08-13
Duloxetine delayed-release capsules exceed the interim nitrosamine impurity limit
Duloxetine Delayed-Release 20 mg capsules packaged by Direct Rx are being recalled because a nitrosamine drug substance related impurity was present above the proposed interim limit. 16 bottles affected.
Product
Duloxetine D/R, 20 mg, 30 Caps, 30-count bottle, RX Only, Packaged & Distributed by: Direct Rx, Dist. By Breckenridge Pharm., Inc., Berlin, CT 06037, NDC 61919-422-30
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0574-2025·2025-08-13
Spironolactone 25 mg tablets recalled after aluminum was found in product
Spironolactone Tablets USP 25 mg are being recalled because of the presence of a foreign substance identified as aluminum. 11,328 bottles are affected.
Product
SPIRONOLACTONE — SPIRONOLACTONE (SPIRONOLACTONE)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-2276-2025·2025-08-13
Guedel airways may carry small burrs that could detach and be inhaled
One-piece Guedel airways, size 3, are being recalled because of potential contamination with small burrs which, if they detach, could be inhaled. 8,640 pieces are affected.
Product
One-piece Guedel airway, size 3, ISO 9.0, yellow. Model Number: 1113090.
Category
Medical Device
Distribution
10 states
HighFDA (Drugs)·D-0553-2025·2025-08-13
Compounded semaglutide 0.22 mg vials recalled over lack of processing controls
Semaglutide + Cyanocobalamin 0.22 mg + 0.25 mg/0.5 mL injection solution compounded by Aequita Pharmacy is being recalled for lack of processing controls. 290 vials are affected.
Product
Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Category
Drug
Distribution
1 state
HighFDA (Devices)·Z-2277-2025·2025-08-13
Stryker SmartPump tourniquet cuff flanges may detach from the bladder
Stryker SmartPump Tourniquet disposable cuffs are being recalled because the cuff flange may become detached from the bladder, which the manufacturer links to a risk of hemorrhage if a leak occurs during a procedure.
Product
Stryker SmartPump Tourniquet, disposable sterile (single use) DISP 18X3,1BLA,1PRT QUICK / 5921-018-135; DISP 18X3,1BLA,2PRT QUICK / 5921-018-235; DISP 24X4,1BLA, 2PRT QUICK / 5921-024-235
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0566-2025·2025-08-13
Doxepin hydrochloride capsules exceed the interim nitrosamine impurity limit
Doxepin Hydrochloride Capsules USP 10 mg from Alembic are being recalled because a nitrosamine drug substance related impurity was present above the proposed interim limit. 9,492 bottles affected.
Product
DOXEPIN HYDROCHLORIDE — DOXEPIN HYDROCHLORIDE (DOXEPIN HYDROCHLORIDE)
Category
Drug
Distribution
Distributed nationwide
HighFDA (Food)·H-0382-2025·2025-08-13
Queen Bee Gardens raspberry whipped honey may contain stainless steel flakes
Queen Bee Gardens Whipped Honey Raspberry in 11 oz jars is being recalled because the product may have small flakes of stainless steel in it. 129 jars are affected.
Product
Brand Name: Queen Bee Gardens Whipped Honey Raspberry. Intended use: spread. Item is shelf stable. Packaging type: Jar. Net wt., 11oz. UPC: 788394182358. Firm Name: Queen Bee Gardens Firm Address: 262 East Main Street, Lovell, WY 82431
Category
Food
Distribution
Distributed nationwide
HighFDA (Food)·H-0385-2025·2025-08-13
Favorite Day frosted sugar cookies may contain wood foreign material
Favorite Day Bakery Frosted Sugar Cookies, 10 count, are being recalled because of foreign material, specifically wood. 803 cases are affected.
Product
Favorite Day Bakery Frosted Sugar Cookies, 10 count, Net Wt 13.5 oz (383g). UPC - 85239-41250 3. Dist. By Target Corporation, Minneapolis, MN 55403. Product of Canada.
Category
Food
Distribution
21 states
HighFDA (Food)·H-0384-2025·2025-08-13
Queen Bee Gardens whipped honey may contain stainless steel flakes
Queen Bee Gardens Whipped Honey Huckleberry in 11 oz jars is being recalled because the product may have small flakes of stainless steel in it. 24 jars are affected.
Product
Brand Name: Queen Bee Gardens Whipped Honey Huckleberry Intended use: spread. Item is shelf stable. Packaging type: Jar. Net wt., 11oz. UPC: 788394182259. Firm Name: Queen Bee Gardens Firm Address: 262 East Main Street, Lovell, WY 82431
Category
Food
Distribution
Distributed nationwide
HighFDA (Food)·H-0383-2025·2025-08-13
Queen Bee Gardens pure whipped honey may contain stainless steel flakes
Queen Bee Gardens Whipped Honey Pure in 11 oz jars is being recalled because the product may have small flakes of stainless steel in it. 112 jars are affected.
Product
Brand Name: Queen Bee Gardens Whipped Honey Pure. Intended use: spread. Item is shelf stable. Packaging type: Jar. Net wt., 11oz. UPC: 788394182006. Firm Name: Queen Bee Gardens Firm Address: 262 East Main Street, Lovell, WY 82431
Category
Food
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0563-2025·2025-08-13
Compounded semaglutide 1.5 mg vials recalled over lack of processing controls
Semaglutide + Cyanocobalamin 1.5 mg + 0.25 mg/0.5 mL injection solution compounded by Aequita Pharmacy is being recalled for lack of processing controls. 190 vials are affected.
Product
Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Category
Drug
Distribution
1 state
HighFDA (Drugs)·D-0558-2025·2025-08-13
Compounded tirzepatide 11.24 mg vials recalled over lack of processing controls
Tirzepatide + Niacinamide 11.24 mg + 1.0 mg/0.5 mL injection solution compounded by Aequita Pharmacy is being recalled for lack of processing controls. 146 vials are affected.
Product
Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Category
Drug
Distribution
1 state
HighFDA (Devices)·Z-2272-2025·2025-08-13
epoc BUN test cards may show a negative sodium bias
epoc BGEM BUN Test Cards are being recalled because a negative sodium bias may exist in some lots, with an observed average bias of -4.4 mmol/L. 37,554 units are affected.
Product
epoc BGEM BUN Test Card [25pk]. Material Number: 10736515.
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0556-2025·2025-08-13
Compounded tirzepatide 6.6 mg vials recalled over lack of processing controls
Tirzepatide + Niacinamide 6.6 mg + 1.0 mg/0.5 mL injection solution compounded by Aequita Pharmacy is being recalled for lack of processing controls. 160 vials are affected.
Product
Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Category
Drug
Distribution
1 state
HighFDA (Drugs)·D-0555-2025·2025-08-13
Compounded tirzepatide 4.4 mg vials recalled over lack of processing controls
Tirzepatide + Niacinamide 4.4 mg + 1.0 mg/0.5 mL injection solution compounded by Aequita Pharmacy is being recalled for lack of processing controls. 170 vials are affected.
Product
Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Category
Drug
Distribution
1 state
HighFDA (Drugs)·D-0561-2025·2025-08-13
Compounded semaglutide 0.44 mg vials recalled over lack of processing controls
Semaglutide + Cyanocobalamin 0.44 mg + 0.25 mg/0.5 mL injection solution compounded by Aequita Pharmacy is being recalled for lack of processing controls. 221 vials are affected.
Product
Semaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Category
Drug
Distribution
1 state
HighFDA (Drugs)·D-0557-2025·2025-08-13
Compounded tirzepatide 8.8 mg vials recalled over lack of processing controls
Tirzepatide + Niacinamide 8.8 mg + 1.0 mg/0.5 mL injection solution compounded by Aequita Pharmacy is being recalled for lack of processing controls. 139 vials are affected.
Product
Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Category
Drug
Distribution
1 state
HighFDA (Drugs)·D-0560-2025·2025-08-13
Compounded tirzepatide 16.6 mg vials recalled over lack of processing controls
Tirzepatide + Niacinamide 16.6 mg + 1.0 mg/0.5 mL injection solution compounded by Aequita Pharmacy is being recalled for lack of processing controls. 155 vials are affected.
Product
Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 3 x 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Category
Drug
Distribution
1 state
HighFDA (Drugs)·D-0565-2025·2025-08-13
Compounded semaglutide 2.67 mg vials recalled over lack of processing controls
Semaglutide + Cyanocobalamin 2.67 mg + 0.25 mg/0.5 mL injection solution compounded by Aequita Pharmacy is being recalled for lack of processing controls. 158 vials are affected.
Product
Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Category
Drug
Distribution
1 state
HighFDA (Drugs)·D-0559-2025·2025-08-13
Compounded tirzepatide 13.2 mg vials recalled over lack of processing controls
Tirzepatide + Niacinamide 13.2 mg + 1.0 mg/0.5 mL injection solution compounded by Aequita Pharmacy is being recalled for lack of processing controls. 143 vials are affected.
Product
Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Category
Drug
Distribution
1 state